Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Agents interfering with the platelet-vessel wall interaction.

H K Nieuwenhuis, J J Sixma

    Pharmaceutisch Weekblad. Scientific Edition
    |February 24, 1984
    PubMed
    Summary

    Drugs inhibiting platelet activation show modest protection against cardiovascular diseases like infarction. Research explores mechanisms of various drug classes, with limited clinical trials demonstrating efficacy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    X-linked sideroblastic anaemia due to ALAS₂ mutations in the Netherlands: a disease in disguise.

    The Netherlands journal of medicine·2014
    Same author

    Elucidation of a novel pathogenomic mechanism using genome-wide long mate-pair sequencing of a congenital t(16;21) in a series of three RUNX1-mutated FPD/AML pedigrees.

    Leukemia·2012
    Same author

    Ultrastructural expression of P-selectin on surface activated platelets.

    Platelets·2010
    Same author

    Low incidence of infectious complications after nonmyeloablative compared with myeloablative allogeneic stem cell transplantation.

    Transplant infectious disease : an official journal of the Transplantation Society·2005
    Same author

    The role of collagen in thrombosis and hemostasis.

    Journal of thrombosis and haemostasis : JTH·2004
    Same author

    Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux.

    Journal of thrombosis and haemostasis : JTH·2003

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine
    • Thrombosis Research

    Background:

    • Platelet activation plays a key role in thrombosis and atherosclerosis.
    • Several drug classes are investigated for their potential to inhibit platelet activation.

    Purpose of the Study:

    • To discuss the mechanisms by which various compounds inhibit platelet activation.
    • To review the clinical efficacy of drugs targeting platelet function.

    Main Methods:

    • Literature review of drug mechanisms affecting platelet activation.
    • Analysis of clinical trial data for drugs like acetylsalicylic acid, dipyridamole, and sulfinpyrazone.

    Main Results:

    • Multiple drug classes, including coumarins and calcium entry blockers, may inhibit platelet activation.
    • Limited clinical studies show modest protective effects of acetylsalicylic acid, dipyridamole, and sulfinpyrazone against cardiovascular events.

    Conclusions:

    • Inhibition of platelet activation is a potential strategy for preventing thrombosis and atherosclerosis.
    • Further research and clinical trials are needed to fully establish the efficacy of antiplatelet agents.

    Related Experiment Videos